Lion's Mane Dosage Guide: Clinical Trial Doses, Extract Conversions & Timing
Most lion's mane dosage advice online is wrong. Not because the numbers are fabricated — but because they ignore a critical factor.
We call it The Accumulation Window.
Lion's mane doesn't work like caffeine. There's no immediate spike. No single-dose transformation. The bioactive compounds — hericenones and erinacines — stimulate nerve growth factor (NGF) production gradually. Your body needs time to respond. Neurons need time to build new connections. The benefits accumulate over weeks, not hours.
Getting the dose wrong means either wasting your money on too little — or overshooting a dose that clinical trials never tested. This guide covers what the research actually used, how to adjust for extract concentration, and how long to give it before judging results.
What Clinical Trials Actually Used
Dosage advice should start with evidence, not marketing. Here is what published human trials tested:
| Study | Daily Dose | Form | Duration | Outcome |
|---|---|---|---|---|
| Mori et al. 2009 (PMID: 18844328) | 3,000 mg | Whole powder in tablets | 16 weeks | Significant cognitive improvement in adults 50–80 with mild cognitive impairment |
| Nagano et al. 2010 (PMID: 20834180) | 2,000 mg | Whole powder in cookies | 4 weeks | Reduced depression and anxiety in menopausal women (n=30) |
| Docherty et al. 2023 (PMID: 38004235) | 1,800 mg | Extract capsules | 28 days | Improved cognitive speed and reduced stress in healthy young adults (n=41) |
| Li et al. 2020 (PMID: 32581767) | 1,050 mg (350 mg × 3) | Erinacine A-enriched mycelia capsules | 49 weeks | Significant MMSE improvement in mild Alzheimer's patients (n=49) |
| 2025 RCT (PMID: 40276537) | Standardised extract | Standardised extract | Single acute dose | Improved cognitive performance at 60 minutes post-dose in healthy younger adults |
Notice the range. Just over one gram to three grams. That variation exists because studies used different preparations — whole mushroom powder is far less concentrated than a standardised extract, and mycelia-based products contain different bioactive profiles to fruiting body extracts.
What this means in practice: You cannot compare doses across studies without accounting for extract concentration and source material. 3 g of whole mushroom powder is roughly equivalent to 300 mg of a 10:1 extract. Most online dosage guides ignore this distinction entirely, leading people to either under-dose with concentrated extracts or over-dose with raw powder.
Understanding Extract Concentration: The 10:1 Ratio
A 10:1 extract means 10 kg of raw mushroom was used to produce 1 kg of final product. The active compounds are concentrated tenfold.
This matters enormously for dosing. Here is the conversion:
| Whole Mushroom Equivalent | 10:1 Extract Dose | Approximate Measure |
|---|---|---|
| 1,000 mg (1 g) | 100 mg | Pinch |
| 2,000 mg (2 g) | 200 mg | ¼ teaspoon |
| 3,000 mg (3 g) — Mori trial | 300 mg | ⅓ teaspoon |
| 10,000 mg (10 g) | 1,000 mg (1 g) | ½ teaspoon |
| 20,000 mg (20 g) | 2,000 mg (2 g) | 1 teaspoon |
Our lion's mane is a 10:1 dual-extracted concentrate with 31.7% beta-glucans. A half-teaspoon serving (~1 g of extract) delivers the equivalent of roughly 10 g of raw mushroom. A full teaspoon (~2 g) delivers the equivalent of 20 g.
This is why "take 3 grams of lion's mane" without specifying the form is meaningless advice. Three grams of what — raw powder, a 4:1 extract, a 10:1 dual extract? The bioactive delivery is vastly different.
Our Lion's Mane: 10:1 Dual-Extracted, 31.7% Beta-Glucans
100% fruiting body, ACO certified organic. Di Tao sourced.
Powder vs Capsule Dosing
Lion's mane supplements come in two primary delivery formats. Both can be effective, but the dosing considerations differ:
Powder (our format): Allows flexible dosing. You can start with ½ teaspoon and gradually increase. Mixes into coffee, tea, smoothies, or warm water. You taste it — the flavour is mild and slightly savoury, less earthy than reishi, less bitter than chaga. Powder also tends to offer better value per gram.
Capsules: Fixed dose per capsule (typically 500 mg). Convenient but less flexible for titrating. If a capsule product uses mycelium-on-grain rather than fruiting body extract, the actual lion's mane content may be significantly diluted by starch filler. Always check the supplement facts panel for beta-glucan content and whether the capsule contains fruiting body or mycelium.
The Docherty 2023 trial (PMID: 38004235) used 1.8 g of extract in capsule form. The Mori 2009 trial (PMID: 18844328) used 3 g of whole mushroom powder in tablets. Both showed positive cognitive outcomes — the format matters less than the quality and concentration of the extract inside.
Recommended Dosage Protocol
Based on the clinical trial evidence, here is our practical recommendation for a 10:1 concentrated extract like ours:
Starting Phase (Weeks 1–2)
Begin with ½ teaspoon (approximately 1 g) daily. This is conservative and allows you to assess tolerance. Most people experience zero side effects, but starting low eliminates any uncertainty.
Take it in the morning with food. Lion's mane mixes well into coffee, tea, smoothies, or warm water. It has a mild, slightly savoury flavour that blends easily into most beverages.
Standard Phase (Weeks 3+)
Increase to 1 teaspoon (approximately 2 g) daily. This aligns with the bioactive equivalent of the successful Mori 2009 and Docherty 2023 trials. Most of our long-term customers settle at this dose.
Higher Dosing
Some users take up to 1½ teaspoons (approximately 3 g). Clinical trials have not reported adverse effects at higher doses, and the 2025 systematic review (PMID: 40959699) confirmed a favourable safety profile across studied doses. However, there is no evidence that more is better above the effective range.
Quick Dosage Reference — 10:1 Extract
Weeks 1–2
Week 3 onwards
Experienced users
The Accumulation Window: When to Expect Results
This is where most people get impatient.
The Accumulation Window for lion's mane is typically 4–8 weeks of daily use. Here is the timeline based on published research:
- Days 1–7: Unlikely to notice anything. Bioactive compounds are entering your system, but NGF stimulation takes time to translate into observable changes. That said, the 2025 RCT (PMID: 40276537) did detect measurable cognitive improvements as early as 60 minutes post-dose on Stroop task performance — suggesting some acute effects may occur even before the longer accumulation begins.
- Weeks 2–3: Some users report subtle shifts — slightly clearer thinking, improved focus during sustained tasks. The Docherty 2023 trial (PMID: 38004235) measured improvements at 28 days in healthy young adults.
- Weeks 4–8: The window where clinical trials consistently show measurable results. The Mori 2009 trial (PMID: 18844328) showed significant cognitive improvements at weeks 8, 12, and 16.
- Weeks 8–49: The Li 2020 Alzheimer's trial (PMID: 32581767) — the longest human lion's mane trial to date — ran for 49 weeks and showed continued MMSE improvement. Benefits appear to deepen with sustained use rather than plateau.
Critically, the Mori trial also showed that benefits declined after supplementation stopped. This isn't a course of medication with an end date. It's ongoing nutritional support for a biological process.
The patience principle: If you try lion's mane for a week and feel nothing, that's expected. The Accumulation Window requires patience. Give it a genuine 4–8 week trial at the standard dose before assessing whether it works for you. Many people who "tried lion's mane and it didn't work" simply didn't take it long enough.
Timing: Morning vs Evening
Lion's mane is not a stimulant. It contains no caffeine, no adaptogens that affect cortisol timing, and no compounds known to interfere with sleep.
That said, most clinical trials administered doses in the morning. Most of our customers take it as part of a morning routine — in coffee, tea, or a smoothie. Some users prefer splitting the dose: half in the morning, half in the afternoon.
There is no published evidence suggesting that timing significantly affects outcomes. Choose whatever helps you be consistent. Consistency matters more than timing.
Stacking: Lion's Mane with Other Mushrooms
Combining lion's mane with other functional mushrooms is common practice. The key principle is that different mushrooms target different systems, so stacking can be complementary rather than redundant.
Lion's mane + reishi: Cognitive support paired with nervous system calm. Some practitioners recommend lion's mane in the morning and reishi in the evening. No published interaction data exists between the two — they have distinct bioactive compound profiles (hericenones/erinacines vs triterpenoids/ganoderic acids).
Lion's mane + cordyceps: Cognitive support paired with physical energy. A common combination for people seeking both mental clarity and physical performance. Again, no documented interactions — the compounds are biochemically distinct.
Lion's mane + chaga: Cognitive support paired with antioxidant and immune support. Both are well-tolerated mushrooms with long traditional use histories.
When stacking, maintain the standard dose of each individual mushroom. There is no evidence that combining mushrooms requires dose reduction of any single one. However, if you're new to functional mushrooms, introduce one at a time so you can identify which is contributing to any changes you notice.
Dosage by Goal
| Goal | Suggested Dose (10:1 extract) | Minimum Duration | Evidence Basis |
|---|---|---|---|
| General cognitive support | 1–2 g daily | 4–8 weeks | Mori 2009, Docherty 2023 |
| Mood and stress support | 1–2 g daily | 4 weeks | Nagano 2010, Docherty 2023 |
| Focus and concentration | 1–2 g daily | 4–8 weeks | Docherty 2023, 2025 RCT |
| Neuroprotective support | 2–3 g daily | 8+ weeks | Mori 2009, Li 2020 (49 wk) |
| Gut microbiome support | 1–2 g daily | 4+ weeks | Beta-glucan prebiotic research |
Who Should Adjust Their Dose
Most healthy adults can follow the standard protocol above. However, some groups should start lower or consult their healthcare practitioner:
- People on blood-thinning medication: Lion's mane may have mild anticoagulant properties. Start at the minimum dose and monitor with your doctor. See our side effects guide for details.
- People with mushroom allergies: Avoid entirely, or trial under medical supervision.
- Pregnant or breastfeeding women: Insufficient safety data exists. We recommend consulting your healthcare practitioner.
- People taking immunosuppressants: Lion's mane has immunomodulatory properties. Discuss with your prescribing doctor.
- Children and adolescents: No clinical trial data exists for under-18s. Not recommended without practitioner guidance.
Our Formulation
- Extraction: Dual extract (ethanol and water) — captures both water-soluble beta-glucans and alcohol-soluble hericenones
- Concentration: 10:1 ratio
- Beta-glucan content: ≥30% specification, 31.7% tested result
- Source: 100% fruiting body, Di Tao regions, China
- Certification: ACO certified organic
- No mycelium-on-grain: Pure fruiting body extract
We grow and formulate our lion's mane specifically to deliver the compounds that clinical research has identified as bioactive. The dual extraction ensures both water-soluble beta-glucans and alcohol-soluble hericenones are present in the final product.
Our Lion's Mane: 31.7% Beta-Glucans, Dual-Extracted
100% fruiting body, 10:1 concentrated extract. Di Tao sourced, ACO certified organic. The same extract type used in the clinical trials referenced throughout this guide.
View Lion's Mane →Honest Limitations of Dosage Research
- No standardised dosing protocol exists. Every clinical trial used a different preparation and dose. Our recommendations are our best interpretation of the evidence, not an established medical guideline.
- Bioavailability data is limited. We know the compounds are biologically active, but absorption rates in the human gut have not been precisely quantified for most lion's mane preparations.
- Individual variation is real. Body weight, gut microbiome composition, and metabolic rate all influence how you respond. The Accumulation Window is a general guideline, not a guarantee.
- Fruiting body vs mycelia dosing differs. The Li 2020 trial used erinacine A-enriched mycelia at just 1,050 mg/day — lower than fruiting body trials — because the bioactive compound profile is different. Most dosage guides do not distinguish between these two source materials.
- Long-term safety data is encouraging but limited. The Li 2020 trial ran for 49 weeks without significant adverse events, and the 2025 systematic review (PMID: 40959699) confirmed a favourable safety profile. However, multi-year data does not yet exist.
For a full overview of the evidence behind lion's mane, see our complete lion's mane benefits guide.
Frequently Asked Questions
This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not medical advice. Consult a qualified healthcare practitioner before starting any supplement.
Continue Your Research
- Lion's Mane Buying Guide: How to Choose a Quality Supplement in Australia
- Lion's Mane for ADHD and Focus: What the Research Actually Shows
- Lion's Mane for Anxiety: What the Research Actually Shows
- Lion's Mane for Gut Health: The Prebiotic Bridge Your Microbiome Has Been Waiting For
- Lion's Mane for Skin: The Ergothioneine Advantage
- Lion's Mane vs Ashwagandha: The NGF-Cortisol Effect Explained
- Lion's Mane and Ashwagandha: The Build-and-Protect Stack
- How to Use Lion's Mane Mushroom Powder